Lansforsakringar Fondforvaltning AB (publ)
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 2059323
Stockholm, V7
Position in ALNY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$12,389,491
-$1,470,653 QoQ
Shares Held
41,157
-1.7% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#168
of 784 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Lansforsakringar Fondforvaltning AB (publ) holds $105,727,306 across 11 Biotechnology names. ALNY ranks #3 (11.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
79,627 | $39,553,119 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
31,436 | $19,601,603 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
41,157 | $12,389,491 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
48,442 | $9,072,217 | |
| 5 | RPRX |
Royalty Pharma plc
|
161,125 | $9,034,278 | |
| 6 | INSM |
INSMED Inc
|
63,437 | $6,763,652 | |
| 7 | INCY |
Incyte Corp
|
47,223 | $5,353,199 | |
| 8 | ONC |
BeOne Medicines Ltd.
|
123,352 | $2,680,317 |
All Filings in ALNY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,389,491 | 41,157 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $13,860,144 | 41,890 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $16,836,501 | 42,340 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $19,336,224 | 42,404 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $13,118,926 | 40,231 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $11,422,656 | 42,303 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $10,011,028 | 42,544 | Shares | Sole | 2025-03-14 | |
| No filing history on record for this holder in this stock. | ||||||